HB92 Alabama 2012 Session

Summary

Primary Sponsor

Kerry Rich

Republican

Co-Sponsors

Lynn GreerEd HenryWayne Johnson

Session

Regular Session 2012

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, wholesale drug distributors exempt from storage, record keeping and security control, Secs. 20-2-20, 20-2-181 am'd.

Summary

HB92 would require ephedrine, pseudoephedrine, and phenylpropanolamine to be sold by prescription by classifying them as Schedule III controlled substances, allow exemptions for formulations designed to prevent meth production, and exempt certain wholesale distributors from some controls.

What This Bill Does

Classifies ephedrine, pseudoephedrine, and phenylpropanolamine as Schedule III controlled substances. Authorizes the State Board of Health to exempt a product containing these ingredients from controlled-substance status if the product is effectively formulated to prevent conversion to methamphetamine, with exemptions revocable if the Department of Public Safety determines the exemption is no longer justified. Exempts wholesale drug distributors licensed by the Board of Pharmacy and registered with the U.S. Drug Enforcement Administration from storage, reporting, record-keeping, and physical security requirements related to these substances.

Who It Affects

• Patients and consumers who use products containing these ingredients would generally need a prescription to obtain them (Schedule III), though some products could be exempt if properly formulated to prevent meth production.
• Wholesale drug distributors and pharmacies that handle these substances would face fewer regulatory requirements for storage, reporting, record-keeping, and security if they qualify for the exemptions.

Key Provisions

• Ephedrine, pseudoephedrine, and phenylpropanolamine are classified as Schedule III controlled substances.
• The Board of Health may exempt a product containing these substances from control if it is effectively formulated to prevent conversion to methamphetamine; the exemption can be revoked on DPS notification that it is no longer effective.
• Wholesale drug distributors licensed by the Board of Pharmacy and registered with the DEA are exempt from certain storage, reporting, record-keeping, and physical security requirements for these substances.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Controlled Substances